Content about Clinical trial

January 10, 2012
Hospira enrolls first patient in biosimilar trial

Generic drug maker Hospira has enrolled the first patient in a late-stage clinical trial of a biosimilar drug for treating kidney disease.

December 22, 2011
Pfizer announces Embeda post-market trial results

A Pfizer painkiller appears to produce a much less positive experience for recreational drug users when crushed than when administered whole, according to results of a post-marketing clinical study program.

December 21, 2011
Genzyme reports lackluster results in MS drug trial

An orally administered drug made by Genzyme for treating multiple sclerosis did not appear superior to a biotech drug already on the market, according to results of a late-stage clinical trial.

December 16, 2011
Lyrica produces 'significant' improvement in restless legs syndrome

A drug made by Pfizer shows "significant" benefit to patients with restless legs syndrome, according to results of a late-stage clinical trial announced Friday.

December 9, 2011
Diplomat, RainTree Oncology Services announce agreement

Diplomat Specialty Pharmacy has signed an agreement with a provider of acquisition and management services for oral cancer drugs that the companies said would allow for better access to the drugs and related programs.

December 7, 2011
Drug shows improvement in symptoms of autism in children

A drug in late-stage clinical trials appears to treat the symptoms of autism, the drug's developer said Wednesday.

December 6, 2011
Pfizer's Toviaz safe, effective in treating overactive bladder in elderly patients

A drug made by Pfizer appears to work in treating overactive bladder in elderly patients, according to results of a clinical trial released Monday.

November 28, 2011
Bayer, Regeneron start phase-3 trial of Eylea for wet AMD in China

Bayer HealthCare and Regeneron Pharmaceuticals have started a late-stage clinical trial in China to evaluate a drug for eye disorders, the companies said Monday.

November 21, 2011
Factor Nutrition presents study on supplement supporting memory

Factor Nutrition Labs on Monday presented a study supporting supplementation with its FocusFactor product to improve brain function before the Gerontological Society of America.

November 18, 2011
FDA revokes breast cancer approval for Avastin

A drug widely used to treat breast cancer is not safe or effective, the Food and Drug Administration said Friday.

November 17, 2011
Bristol-Myers Squibb, AstraZeneca present analysis of dapagliflozin studies

Bristol-Myers Squibb and AstraZeneca presented an analysis Wednesday of 14 clinical trials at the American Heart Association's Scientific Sessions in Orlando, Fla., the companies said.

November 17, 2011
GSK announces results of late-stage clinical trial for albiglutide

GlaxoSmithKline announced the results from the first of eight phase-3 clinical trials that examined the efficacy of albiglutide in the treatment of Type 2 diabetes.

November 14, 2011
Genzyme announces phase-3 results of Lemtrada in patients with relapsing MS

A late-stage clinical trial of a drug under development as a treatment for multiple sclerosis has shown "successful" results.

November 10, 2011
AstraZeneca, Targacept: TC-5214 'well-tolerated,' did not meet endpoint in phase-3 trial

AstraZeneca and Targacept released results of the first of four phase-3 clinical trials that investigated the efficacy and tolerability of a drug that could serve as an adjunct therapy to major depressive disorder patients that had an inadequate response to initial antidepressant therapies.

November 7, 2011
Abbott announces results of phase-3 trial of Humira

A large number of patients with a serious form of arthritis experienced improvement in their condition after taking a drug made by Abbott Labs for three months, according to results of a late-stage clinical trial announced Monday.

November 2, 2011
FDA approves update to Takeda cancer drug label

The Food and Drug Administration has approved changes to the labeling of a cancer drug made by Takeda Pharmaceuticals, the drug maker said.

October 25, 2011
Lilly removes Xigris from market

Eli Lilly is withdrawing one of its drugs from the market after clinical trials showed it to be ineffective.

October 19, 2011
Takeda launches late-stage trial program for Type 2 diabetes drug

Takeda Pharmaceuticals has started a late-stage clinical trial program for a drug to treat Type 2 diabetes, the drug maker said.

October 6, 2011
Sanofi MS drug shows good results in phase-3 trial

A drug under investigation by Sanofi for multiple sclerosis improved several measures of disease activity in patients, according to results of a late-stage clinical trial.

September 22, 2011
J&J HIV drug shows fewer side effects in trial data analysis

A new study has found that a recently approved drug for HIV produces fewer unpleasant side effects during the first three months of therapy than the standard treatment, according to published reports.

September 19, 2011
Merck drug for HIV effective, tolerated, study results show

A drug made by Merck for treating HIV infection was effective and tolerated in patients regardless of their gender or race, according to results of a late-stage clinical trial announced Monday.

September 15, 2011
GSK, Amicus start phase-3 trial of Fabry disease drug

GlaxoSmithKline and Amicus Therapeutics have started a late-stage clinical trial for a drug to treat a rare genetic disorder, the companies said.

August 23, 2011
Amgen expects FDA decision on new indication for cancer drug by next April

The Food and Drug Administration will decide whether or not to approve a new usage for a cancer drug made by Amgen by next year, the drug maker said.

August 17, 2011
Savient gout drug shows improvements, according to study

Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

August 15, 2011
Study: Investigational GSK, Impax drug reduces Parkinson's symptoms

Patients taking an experimental treatment for Parkinson's disease experienced greater reduction in symptoms than those taking standard therapies, according to results of a late-stage clinical trial.

© 2013 Drug Store News. All Rights Reserved.